US FDA approves GSK's combo meningococcal vaccine
The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal infection for use in people aged 10 through 25 years, the company said on ...
FiercePharma21 天
With new FDA approval, GSK joins Pfizer in the 5-in-1 meningococcal vaccine ring
The shot mixes the antigenic components of GSK’s established meningococcal vaccines Bexsero and Menveo, which target MenB and MenACWY, respectively, to offer broader coverage in fewer doses.
HealthDay on MSN10 天
FDA Approves More Broadly Protective Meningococcal Vaccine
The US FDA has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive meningococcal disease.
Monthly Prescribing Reference18 天
Pentavalent Meningococcal Vaccine Penmenvy Gets FDA Approval
Following vaccination ... was observed with Penmenvy vs 2 doses of Bexsero for the proportion of participants with a seroresponse against meningococcal serogroup B indicator strains for fHbp ...
Benzinga.com17 天
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory ...
The vaccine combines the antigenic components of GSK’s two well-established meningococcal vaccines, Bexsero (Meningococcal Group B Vaccine) and Menveo (Meningococcal [Groups A, C, Y, and W-135 ...
Reuters21 天
US FDA approves GSK's combo meningococcal vaccine
The pentavalent vaccine targets the five most common bacterial strains causing the infection - Men A, B, C, W and Y. Bexsero is approved for the prevention of invasive meningococcal disease caused ...
Medical Xpress18 天
FDA approves more broadly protective meningococcal vaccine
The vaccine combines components from Bexsero and Menveo and demonstrated safety and efficacy in phase 3 trials with over 4,800 participants. Common side effects include injection site pain ...
PMLiVE19 天
GSK’s five-in-one meningococcal vaccine Penmenvy granted FDA approval
GSK’s Penmenvy combines the antigenic components of its approved Bexsero and Menveo meningococcal vaccines to target five common IMD-causing serotypes (A, B, C, W and Y). It is hoped that the ...
Infectious Disease Advisor15 天
Pentavalent Meningococcal Vaccine Penmenvy Gets FDA Approval
Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
WebMD17 天
FDA Approves 5-in-1 Vaccine Against Meningococcal Disease
Penmenvy combines parts of the well-established Bexsero and Menveo vaccines ... with a safety profile similar to GSK’s licensed meningococcal vaccines, according to the news release by GSK.
Yahoo Finance19 天
GSK’s Penmenvy meningococcal vaccine gains FDA approval
Penmenvy is a combination of antigens from GSK's established vaccines: Bexsero (Meningococcal Group B vaccine) and Menveo (Meningococcal [Groups A, C, Y, and W-135] Oligosaccharide Diphtheria ...